NRx Pharmaceuticals, Inc. Announces Pricing of $1.5 Million Underwritten Public Offering of Common Stock Together with investor Commitment for Additional $1 million

NRx Pharmaceuticals, Inc. today announced the pricing of its underwritten public offering of  shares of its common stock (or pre-funded warrants in lieu thereof) at a public offering price of $0.30 per share.